1. Introduction {#sec1}
===============

*Pseudomonas aeruginosa* sp. is deemed one of the major etiological agents of both acute and chronic human infections ranging from minor skin infections to persistent and often life-threatening diseases in hospitalized or immunocompromised patients \[[@B1], [@B2]\]. Infections caused by this organism are difficult to treat due to the ability of this bacterium to resist multiple classes of antibiotics \[[@B3]\]. Strains of *P. aeruginosa* are well known to employ their high levels of intrinsic and acquired resistance mechanisms to combat most antibiotics \[[@B4]\]. In addition, pathogenesis of *P. aeruginosa* is multifactorial, and many virulence factors are produced that include secreted factors such as cytotoxic pigment pyocyanin, siderophores, alkaline protease, elastase, exotoxin A, rhamnolipid structural component lipopolysaccharide, pili, flagella, and biofilm formation \[[@B5]\]. Therefore, alternative drugs and new therapeutic strategies that present novel avenues against *P. aeruginosa* infections are increasingly required and gaining more and more attention \[[@B4]\]. Previous studies by our research group demonstrated that *K*~F~ can induce *P. aeruginosa* cell wall damage \[[@B6], [@B7]\]. Thus, we decided to investigate the gene expression profile of *P. aeruginosa* growing in kaempferol-3-*O*-(2′,6′-di-*O-trans*-*p-*coumaroyl)-*β*-D glucopyranoside isolated from *Melastoma malabathricum* known to locals in Malaysia as "senduduk." Next-generation sequencing (NGS) technology may provide a detailed view of *P. aeruginosa* adaptation and behaviour in response to *K*~F~ and could help researchers further understand the transcriptomic response of *P. aeruginosa* to *K*~F~ exposure \[[@B8]\]. We compared the transcriptional responses of *P. aeruginosa* upon exposure to *K*~F~ at an early time point (6 h incubation) and at a late time point (24 h incubation) to provide information about the *K*~F~ mechanism of action. Transcriptomic data highlighted a marked modulation of gene expression characterized by the induction of the expression of several genes involved in pathogenesis, iron acquisition, DNA replication and repair, and metabolic adaptation to *K*~F~ growth conditions. The results presented in this study provide a detailed view of gene expression changes in *P. aeruginosa* in response to *K*~F~ exposure, facilitating the understanding of the cellular strategies that are utilized under *K*~F~ exposure conditions and identifying a potential mechanism for the inhibition of *P. aeruginosa* after *K*~F~ exposure.

2. Materials and Methods {#sec2}
========================

2.1. Bacteria and Growth Conditions {#sec2.1}
-----------------------------------

*P seudomonas aeruginosa* strain ATCC 10145 was cultivated in Nutrient Broth (Oxoid, UK) with a shaking incubator at 151 rpm for 3 to 6 h at 37°C to achieve log phase growth. At the log phase (∼6 h incubation), *K*~F~ was added to the *P. aeruginosa* culture in Mueller Hinton Broth (Oxoid, UK) at a density of 4 × 10^5^ CFU/mL to achieve a final concentration of 0.5 mg/mL dissolved in 5% dimethyl sulfoxide (DMSO). DMSO (5%) was used as a negative control for untreated cells. The cultures were incubated at 37°C with a shaking incubator at 200 rpm.

2.2. RNA Extraction, cDNA Library Construction, and Illumina Sequencing {#sec2.2}
-----------------------------------------------------------------------

Total RNA was extracted from *P. aeruginosa* (treated or untreated) and harvested after 6 h and 24 h of incubation. RNA was extracted using an innuPREP RNA Mini Kit (Analytik Jena Biometra, Germany). The quantity and integrity were first determined using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, USA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). The total RNA was depleted of rRNA using a ScriptSeq™ Complete Kit (Bacteria; Epicenter, San Diego, CA, USA). Total RNA samples were used for cDNA synthesis. Magnetic beads with attached poly T oligos were used to purify mRNA from the total RNA. The mRNA was then cleaved into small fragments by the addition of RNA fragmentation solution. First strand cDNA was synthesized using random hexamer adaptors and StarScript Reverse Transcriptase, followed by the synthesis of second strand cDNA using ScriptSeq v2 Terminal Tagging Premix and DNA polymerase. Exonuclease and polymerase were used to blunt and adenylate the 3′ ends of the DNA fragments, and Illumina PE adapter oligonucleotides were ligated to prepare for hybridization. The cDNA fragments (280 bp) were purified using the Pure AMXP system (Beckman Coulter, Beverly, CA, USA). The cDNA fragments with ligated adaptor molecules were enriched using Illumina PCR Primer Cocktail in a 15-cycle PCR. Finally, the cDNA library was sequenced on the Illumina MiSeq platform (San Diego, CA, USA) using single-end technology in a single run at the Institute of Biosciences, Universiti Putra Malaysia. The Illumina MiSeq software was used to perform the original image processing for sequencing, base calling, and quality value calculations, where 50 bp single-end reads were obtained.

2.3. Analysis of the Differentially Expressed Genes (DEGs) {#sec2.3}
----------------------------------------------------------

The raw reads were filtered to obtain the high-quality clean data by removing adaptor sequences and low-quality reads with the Phred quality score ≤30. The clean reads were then mapped to the *P. aeruginosa* PA01 genome (NCBI reference sequence, [NC_002516.2](http://www.ncbi.nlm.nih.gov/nuccore/NC_002516.2); GenBank accession number AE004091.2). FASTQ read values were calculated and normalized to transform into expression values by using CLC Genomics Workbench version 6.5. Differential expression analysis (fold changes) for RNAseq data was performed to compare two different samples (untreated versus treated samples) using Kal\'s *Z*-test. Genes with average fold changes \>2 and adjusted *p* values less than 0.05 (i.e., false discovery rate less than 5%) were identified as significant DEGs. To better understand the biological functions and the metabolic pathways of the identified genes, the DEGs were functionally classified due to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. The significant DEGs at both 6 h and 24 h were compiled and used to generate a Venn diagram through an online interactive tool \[[@B9]\]. The gene lists of unique and shared genes in each group identified in the Venn diagram were analysed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) (<http://david.abcc.ncifcrf.gov/home.jsp>). The DAVID database provides a comprehensive set of functional annotation tools to understand the biological meaning behind the DEGs, including visualizing genes on KEGG pathway maps. In addition, the obtained data were then compiled with public datasets downloaded from the *Pseudomonas* Genome Database (<http://www.pseudomonas.com>) for further analysis. The raw RNA-seq data have been submitted to the NCBI Sequence Read Archive (NCBI SRA) under GenBank accession no. SRP060687 (NCBI SRA, <http://www.ncbi.nlm.nih.gov/sra?term=SRP060687>).

2.4. Validation of DEGs by Quantitative Real-Time PCR (qRT-PCR) {#sec2.4}
---------------------------------------------------------------

In order to validate the RNA-seq data and to have a concise view of *P. aeruginosa* gene expression profiles over time, qRT-PCR was employed and gene expression levels were analysed on a subset of genes whose functions were documented to contribute to *P. aeruginosa* virulence. Four genes with different expression patterns at two time points were chosen for the validation of the RNA-seq results. The template cDNAs were synthesized from 1 *μ*g of total RNA using oligo (dT)~18~, random hexamer primers, and reverse transcriptase enzyme mix (Maxima First Strand cDNA Synthesis Kit; Thermo Scientific, USA). A Luminaris Color HiGreen Fluorescein qPCR Master Mix (Thermo Scientific, USA) was used as a labelling agent, and L-aspartate oxidase (*nadB*) served as an internal reference gene. The reaction mixture (20 *μ*L) contained 2 × Master Mix (10 *μ*L), 10 *μ*M forward and reverse primers (1.2 *μ*L and 0.6 *μ*L of each), template cDNA (2 *μ*L), and RNase-free water (6.8 *μ*L). The PCR program was as follows: 2 minutes (min) at 50°C, 10 min at 95°C, followed by 40 cycles for 15 seconds (sec) at 95°C, 40 cycles of 30 sec at 53°C and 40 cycles of 30 sec at 72°C. The reaction was performed on an iCycler iQ5 instrument (Bio-Rad Laboratories, Inc., Hercules, Canada). Two independent biological replicates were included for each sample. The relative expression of a target gene in comparison to a reference gene expression level was calculated using Relative Expression Software Tool Multiple Condition Solver REST-MCS©-version 2 (<http://rest.gene-quantification.info>).

3. Results {#sec3}
==========

3.1. Transcriptomic Analysis {#sec3.1}
----------------------------

Genome-wide transcriptomic analysis was conducted to elucidate the mechanism through which *K*~F~ exerts its killing effect on *P. aeruginosa* using NGS technology. After statistical analysis (Kal\'s *Z*-test), 2405 of the 5681 genes that comprise the *P. aeruginosa* genome were found to be significantly differentially regulated (*p* ≤ 0.05). A total of 2405 differentially expressed genes were classified based on the *Pseudomonas* Genome Database, KEGG pathways, individual operons, and genes potentially encoding targets associated with virulence factors.

Further analysis revealed that 1031 genes showed statistically significant upregulation (\>2.0-fold) or downregulation (\>2.0-fold) of expression at 6 h and 24 h of exposure to *K*~F~. [Figure 1](#fig1){ref-type="fig"} illustrates that more downregulated genes in the functional classes were generally observed at 24 h compared to 6 h of incubation. The most noticeable number of downregulated genes among all functional classes was hypothetical, unclassified, and unknown (HUU) with unknown function.

Note that 803 of 1031 genes were excluded as hypothetical proteins (HUUs). The Venn diagram for the remaining 228 genes at the two time points shows more uniquely over-represented genes at 24 h (115) than at 6 h (53), suggesting a difference between the early and late responses of *P. aeruginosa* to *K*~F~ ([Figure 2](#fig2){ref-type="fig"}). A total of 228 genes were placed in six groups based on their expression change direction ([Figure 3](#fig3){ref-type="fig"}).

### 3.1.1. Group I: Genes with Upregulated Expression at 6 h and 24 h {#sec3.1.1}

Group I consisted of genes with upregulated expression at both 6 h and 24 h of exposure to *K*~F~ ([Table 1](#tab1){ref-type="table"}). Growth under *K*~F~ exposure conditions induced changes in the expression of genes associated with ATP-binding cassette (ABC) transporters (*agtABCD* operon, PA4500), carbohydrate transporters (PA3190), and inorganic ion transporters (PA3514).

Group I also contained genes coding for the type III secretion system (T3SS). These genes with upregulated expression include those involved in the secretion and translocation machinery into the host cell plasma (*popBD* and *pcrV*); transcription and initiation (*exsCED*); chaperones that bind secreted proteins to facilitate the secretion process (*spcS*, *pcrH*, *pscG*, and *exsC*); and effector proteins that are injected into host cells (*exoSTY*; [Table 1](#tab1){ref-type="table"}).

### 3.1.2. Group II: Genes with Upregulated Expression at 6 h {#sec3.1.2}

Group II is composed of genes with expression levels that increased only at 6 h of exposure to *K*~F~ ([Table 2](#tab2){ref-type="table"}). The expression of genes involved in the biosynthesis of several amino acids, including histidine (*hisC1* and *hisE*), arginine (*argF* and *argJ*), isoleucine (*ilvA1*), leucine (*leuA* and *leuC*), and phenylalanine (*pheA*), was increased after *K*~F~ exposure. In addition, we observed the overexpression of genes related to translation class, including genes encoding 30S and 50S ribosomal proteins (the two most upregulated genes, 30S and 50S, are listed in [Table 2](#tab2){ref-type="table"}); aminoacyl-tRNA synthetases associated with tryptophan (*trpS*), tyrosine (*tyrZ*), glycine (*glyQ*), glutamine (*glnE*), valine (*valS*), proline (*pros*), cysteine (*cysS*), and isoleucine (*ileS*); translation initiation factor (*infC*); elongation factor G (*fusA2*); and peptide chain release factor (*prfC*) in response to *K*~F~ treatment.

As shown in [Table 2](#tab2){ref-type="table"}, the upregulation of the expression of genes involved in the first step of long-chain fatty acid biosynthesis was also observed. The genes with upregulated expression include those encoding biotin carboxyl carrier protein (*accB*) and acetyl CoA carboxylase beta subunit (*accD*). In prokaryotes, this step involves the ATP-dependent carboxylation of acetyl coenzyme A (CoA) to form malonyl CoA by the enzyme acetyl CoA carboxylase. In addition, the expression of *fabA* and *fabB* genes, which are involved in the biosynthesis of unsaturated fatty acids (UFAs), was increased in *K*~F~ samples. Under anaerobic conditions, *P. aeruginosa* can utilize nitrate, nitrite, or nitrous oxide instead of oxygen as a terminal electron acceptor in the denitrification process. The expression of the nitric oxide reductase gene (*norB*) required for denitrification was upregulated. Furthermore, the most obvious upregulation of gene expression was found in the oxidative phosphorylation pathway. NADH created by the Krebs cycle can be fed into the oxidative phosphorylation pathway. The expression of NADH dehydrogenase I chain (*nuoBDFGHIJLMN)* in the oxidative phosphorylation pathway was increased. The *anr* gene encodes the transcriptional regulator Anr, which is involved in controlling *P. aeruginosa* gene expression under anaerobic conditions was significantly increased in *K*~F~-treated samples, with log2-fold changes of 3.84. [Table 2](#tab2){ref-type="table"} also shows that the expression of genes related to the flagella assembly pathway (*flgBCDEGIJK* and *fliEFG*) was also increased after *K*~F~ exposure.

### 3.1.3. Group III: Genes with Downregulated Expression at 6 h {#sec3.1.3}

The expression of genes associated with adaptation, protection, and secreted factor functional class was downregulated ([Table 3](#tab3){ref-type="table"}). The genes with downregulated expression include those associated with pyocin S2 (*pys2*) and pyocin S2 immunity protein (*imm2*). The expression of *cobODUJ* genes, which are involved in the aerobic cobalamin biosynthesis process (a cofactor for numerous enzymes mediating methylation, reduction, and intramolecular rearrangements), was reduced.

### 3.1.4. Group IV: Genes with Upregulated Expression at 24 h {#sec3.1.4}

Exposure to *K*~F~ increased changes in the expression of genes associated with tripartite ATP-independent periplasmic transporters, including *dctP* (a C~4~ dicarboxylate-binding protein) and *dctQ* and *dctM* (C~4~ dicarboxylate transporters) ([Table 4](#tab4){ref-type="table"}). *Pseudomonas. aeruginosa* preferentially uses C~4~ dicarboxylates, such as malate, fumarate, and succinate, as carbon and energy sources under anaerobic conditions.

### 3.1.5. Group V: Genes with Downregulated Expression at 24 h {#sec3.1.5}

Group V is composed of genes with downregulated expression at 24 h of exposure to *K*~F~ ([Table 5](#tab5){ref-type="table"}). The expression of the *pchR* gene, which encodes elements involved in iron Fe^3+^ acquisition, was reduced. In addition, growth under *K*~F~ exposure conditions reduced the changes in the expression of genes including members of the extracytoplasmic factor (ECF) subfamily (PA0471-PA0472, PA1300-1301, PA3899-PA3900, PA4895-PA4896, PA0149, PA1912, and PA2896). The expression of the *tonB* gene (TonB-dependent siderophore receptor) required for chelating Fe^3+^ was reduced. Furthermore, the expression of genes encoding fumarate hydratase (*fumC1*), superoxide dismutase (*sodM*), haemeoxygenase (*hemO*), and oxidoreductase (PA0853 and PA3768) was downregulated.

[Table 5](#tab5){ref-type="table"} also shows that the expression of virulence-associated genes that are involved in phenazine-1-carboxylic acid (PCA) biosynthesis (*phzA1B1C1A2B2*) and the conversion of PCA to pyocyanin (*phzMS*) were decreased. The expression of several genes associated with Sec system proteins was significantly altered. Exposure to *K*~F~ reduced the changes in the expression of genes such as the inner membrane translocase subunit proteins (*secD*), a cytoplasmic membrane-associated ATPase (*secA*), and a chaperone (*secB*) that binds to presecretory target proteins. The results also showed a downregulation of the expression of the *mexGHI*-*opmD* efflux pump system in the *K*~F~-treated samples ([Table 5](#tab5){ref-type="table"}). In addition, the expression of several genes involved in the LPS biosynthesis process, including *lpxA*, *lpxB*, *waaF*, *waaG*, *waaP*, PA4998, PA5007, PA5008, and *rmlA,* was decreased. Transcription data of *P. aeruginosa* showed a downregulation in the expression of type VI pili composed of *pilDFMNOPQUVWXY1*. The expression levels of *vfr* (virulence factor regulator) and *pilGHIJ-chpAB* (Chp chemosensory system) genes were significantly decreased according to the Log2-fold changes. The virulence-associated *fliC* gene, which encodes flagellin type B, was downregulated under *K*~F~ exposure conditions.

Growth under *K*~F~ conditions reduced the expression of genes associated with translation class, including genes encoding the 30S and 50S ribosomal proteins (the two most downregulated 30S and 50S genes are listed in [Table 5](#tab5){ref-type="table"}) and aminoacyl-tRNA synthetase associated with glutamine (*glnS*), glycine (*glyS*), leucine (*leuS*), lysine (*lysS*), proline (*proS*), valine (*valS*), and aspartate (*aspS*). In addition, the expression of genes involved in the biosynthesis of several amino acids, including histidine (*hisF1* and *hisG*), arginine (*argB*, *argG*, and *argH*), cysteine (c*ysM*), and tryptophan (*trpA* and *trpB*), was also decreased after exposure to *K*~F~.

RNA-seq data showed a downregulation in the expression of genes associated with DNA replication (*dnaJ*, *dnaK*, *dnaA,* and *holC*) and repair mechanism (*mutL*, *phr*, *sbcD*, *uvrC*, *uvrD*, and *recG*) ([Table 5](#tab5){ref-type="table"}).

This group also contained several genes related to cytochrome c, which is highly expressed under microaerobic conditions. These genes with downregulated expression include those encoding elements in cytochrome c (*ccmEG*, PA1600, and PA4571) and cbb3-1 cytochrome c terminal oxidases (*ccoO1Q1* and PA4133).

The expression of NADH dehydrogenase I chain subunits (*nuoD* and *nuoE*) in the oxidative phosphorylation pathway was significantly decreased in *K*~F~-treated samples, with log2-fold changes of −2.216 and −2.162, respectively. [Table 5](#tab5){ref-type="table"} also shows that the expression of genes involved in energy production in the absence of oxygen through denitrification was decreased after *K*~F~ treatment. These genes with downregulated expression include those encoding nitrate/nitrite transporters (*narK*~1~ and *narK*~2~), the dissimilatory nitrate reductase (*narG* and *narJ*), the two-component regulator NarL, and the transcriptional regulator Dnr.

### 3.1.6. Group VI: Genes with Downregulated Expression at 6 h and 24 h {#sec3.1.6}

This group consisted of genes with downregulated expression at both 6 h and 24 h ([Table 6](#tab6){ref-type="table"}). Growth under *K*~F~ exposure conditions induced the downregulation of the expression of genes encoding heat shock proteins (*hslVU*, *htpG,* and *grpE*). The expression of the *clpB* gene, which encodes the ATP-binding subunit protease, was also downregulated under *K*~F~ exposure conditions.

In this group, we observed the downregulation of the expression of genes involved in the initiation stage of biofilm formation (*bfiR* and *bfiS*) in *K*~F~-treated *P. aeruginosa* samples. Biofilm formation in *P. aeruginosa* is regulated by three novel two-component regulatory systems that are involved in (i) the initiation of biofilm formation (BfiRS), (ii) biofilm maturation (BfmRS), and (iii) microcolony formation (MifRS).

3.2. Validation of NGS Results Using Quantitative Real-Time PCR (qRT-PCR) {#sec3.2}
-------------------------------------------------------------------------

Four genes identified from RNA-seq data (*uvrD*, *sodM*, *fumC1*, and *rpsL*) were selected for qRT-PCR analysis. *nadB* (PA0761) was chosen as the reference control gene that exhibited no change in our transcriptomic data at two treatment times. qRT-PCR data showed the same trend of either upregulation or downregulation of the genes as that in NGS, thereby validating our NGS results ([Table 7](#tab7){ref-type="table"}). The variations were due to the difference in the sensitivity of the two assays.

4. Discussion {#sec4}
=============

Previous studies have elucidated that *K*~F~ can inhibit *P. aeruginosa* growth \[[@B6], [@B7]\]. In regard to this inhibitory effect, the approach of transcriptomic analysis is useful to identify the differentially expressed genes in this bacterium. The transcriptome profiles of *P. aeruginosa* treated with *K*~F~ were examined to demonstrate the changes in gene expression at two time points (6 h and 24 h incubation). Functional analyses were performed to clarify the possible mechanisms underlying the changes in gene expression from a global perspective. In addition, qRT-PCR was used to confirm the RNA-seq results of select genes.

The type III secretion system (T3SS) regulates the virulence of many pathogenic bacteria \[[@B10]\]. The T3SS system is essential for the export of effector proteins through a needle-like structure directly inside target host cells \[[@B10]\]. Transcriptome data showed the continuous upregulation of all T3SS apparatus, regulators, and effector proteins in *P. aeruginosa* at 6 h and 24 h of *K*~F~ treatment ([Table 1](#tab1){ref-type="table"}). Interestingly, the expression of *P. aeruginosa* genes involved in the flagella assembly pathway, which mediates swimming motility and functions in biofilm development, was increased \[[@B11]\]. These findings indicate that the T3SS system and flagella assembly pathway are tuned by different environmental stresses, which might be an essential survival strategy for this bacterium \[[@B12]\].

As shown in [Table 2](#tab2){ref-type="table"}, gene expression analysis of *P. aeruginosa* grown in *K*~F~ for 6 h displayed an upregulation of the operon *fabAB* ([Table 2](#tab2){ref-type="table"}), which is involved in the biosynthesis of unsaturated fatty acids (UFAs). UFAs are required to maintain the fluidity of bacterial membranes \[[@B13]\]. Thus, we assume that the membrane lipid composition might be altered to allow growth under *K*~F~ exposure conditions.

*Pseudomonas aeruginosa* has a highly complex respiratory chain with multiple terminal oxidases and can respire both oxygen and nitrogen oxides \[[@B14], [@B15]\]. Under anaerobic conditions, *P. aeruginosa* can respire through denitrification \[[@B16]\]. In this process, four reductases (nitrate-, nitrite-, NO-, and nitrous oxide reductases) allow bacterial growth \[[@B17]\]. Thus, during this process, molecular oxygen is replaced by nitrate as the terminal electron acceptor \[[@B18]\]. The *P. aeruginosa* genome encodes three NADH dehydrogenase chains (NADH-I, NADH-II, and Nqr). When oxygen is not available, the NADH-I chain encoded by the *nuoA-N* operon is required to translocate protons and oxidize NADH to NAD^+^ \[[@B19], [@B20]\]. Chain I links the NADH ubiquinone electron transfer to the transmembrane transport of protons, leading to the production of a proton motive force that is fundamental for ATP synthesis \[[@B21]\]. In prokaryotic microorganisms, ATP synthesis generally occurs by glycolysis using substrate-level phosphorylation and by the oxidative phosphorylation pathway \[[@B11]\]. In the present study, genes associated with the NADH dehydrogenase I chain, which is involved in the oxidative phosphorylation pathway, displayed a very strong induction at 6 h ([Table 2](#tab2){ref-type="table"}), followed by a reduction at 24 h ([Table 5](#tab5){ref-type="table"}). The expression of chain I subunits (*nuo*-operon) in the oxidative phosphorylation pathway was increased in *K*~F~-treated samples at 6 h. The NADH-I chain is coupled to the denitrification pathway \[[@B22], [@B23]\]. The upregulation of genes encoding NADH-I chain was paralleled by the increased expression of *anr* gene involved in controlling *P. aeruginosa* gene expression under anaerobic conditions, suggesting that *K*~F~-treated cells underwent a switch to anaerobic respiration in response to oxidative stress. Zimmermann et al. \[[@B24]\] noted that the *anr* deletion mutant of *P. aeruginosa* does not grow anaerobically. In addition, the expression of genes encoding several elements of the ATP-binding cassette transporters (ABCs), which exist in all bacterial species and provide a pathway for substrates to cross the cell membrane \[[@B25]\], was upregulated ([Table 1](#tab1){ref-type="table"}). Interestingly, the growth of *P. aeruginosa* under *K*~F~ exposure conditions at two time points led to the increased expression of genes encoding ABC transporters of amino acids, carbohydrates, and inorganic ions ([Table 1](#tab1){ref-type="table"}). As amino acids are key intermediates in bacterial metabolism, the increase in the ABC transporter proteins led to increased amino acid or peptide uptake. In conclusion, to maintain energy consumption, the cell increases the oxidative phosphorylation pathway and the expression of ATP synthase to produce ATP.

During host infection, *P. aeruginosa* utilizes several systems to acquire iron from the surrounding environment \[[@B26]\]. The iron acquisition mechanisms include the production of siderophores (pyoverdine and pyochelin) and heme uptake \[[@B27]\]. Transcriptomic analysis showed a downregulation of the expression of genes involved in iron acquisition in *K*~F~-treated samples at 24 h of *P. aeruginosa* growth. As shown in [Table 5](#tab5){ref-type="table"}, TonB-dependent siderophore receptor (*tonB*) and haemeoxygenase (*hemO*) showed a reduction in the expression level at 24 h. The downregulation of the expression of *pchR*-encoding elements involved in iron Fe^3+^ acquisition was also observed. In addition, the expression of genes highly regulated by iron starvation was repressed by *K*~F~ treatment. These genes encode members of the ECF subfamily, which is mainly associated with extracellular functions that include the regulation of periplasmic stress, iron transport, metal ion efflux systems, alginate secretion, and synthesis of membrane-localized carotenoids \[[@B28]\]. Consequently, the results suggested that *K*~F~-treated cells underwent conditions of excess intracellular iron, which led to the downregulation of the expression of genes regulated by the ferric uptake regulator (Fur) required for iron acquisition. Ochsner et al. \[[@B29]\] reported that the Fur protein uses Fe^2+^ as a cofactor and binds to Fur-Fe^2+^, resulting in the repression of the genes encoding pyochelin and pyoverdin proteins in iron-replete environments. Furthermore, transcriptomic analysis also showed the downregulation of the expression of genes coding for the components of the DNA replication and repair machinery in *P. aeruginosa* at 24 h of *K*~F~ treatment. A superoxide (O~2~^−^) byproduct is formed by the autoxidation of a variety of reduced electron carriers and redox enzymes \[[@B30]\]. O~2~^−^ is implicated in the production of oxidative DNA damage by the steady release of iron from storage proteins into the cytosol, and thus, the free iron binds DNA and catalyses electron transfer from the reductant to H~2~O~2~ \[[@B31], [@B32]\]. The resultant ferryl or hydroxyl radical attacks the adjacent DNA \[[@B33]\]. The repression of genes encoding DNA repair proteins was coupled with the repression of genes involved in iron regulation at 24 h, suggesting that *K*~F~-treated cells were exposed to an excess concentration of intracellular free iron, leading to either hydroxyl or ferryl radical production, which promotes oxidative DNA damage by increasing the amount of DNA-bound iron. Oxidative DNA damage was also evident by the downregulation of the expression of genes involved in defence (*sodM*) against reactive oxygen species.

*P. aeruginosa* pathogenicity depends on the production and secretion of a large variety of virulence factors, including pyocin S2, in response to host environments. pyocin S2 is a protease-sensitive bacteriocin produced by *P. aeruginosa* that kills sensitive cells by damaging chromosomal DNA through its DNase activity and the inhibition of lipid synthesis \[[@B34]\]. RNA-seq analysis showed reduced expression levels of pyocin S2 protease at 6 h of exposure to *K*~F~ ([Table 3](#tab3){ref-type="table"}). As shown in [Table 5](#tab5){ref-type="table"}, the growth of *P. aeruginosa* under *K* treatment conditions at 24 h led to the decreased expression of genes involved in the LPS biosynthesis process (*lpxA*, *lpxB*, *waaF*, *waaG*, *waaP*, PA4998, PA5007, PA5008, and *rmlA*). LPS is the major component defining the outer membrane of Gram-negative bacteria. The outer membrane is essential for viability and mediates virulence and resistance to toxic and antibacterial agents \[[@B35]\]. Interestingly, a previous study revealed that the *waaP* gene in *P. aeruginosa* is required to produce full-length LPS, which is recognized by the outer membrane transport assembly machinery in this bacterium \[[@B36]\]. Therefore, *waaP* may constitute a good target for the development of novel antipseudomonal agents. Our previous observation is consistent with this finding. Transmission electron microscopy studies have revealed that cells treated with *K*~F~ exhibit severe membrane damage concurrent with the disruption of membrane integrity, leading to the loss of intracellular material at 24 h of incubation \[[@B7]\]. These results suggest that LPS biosynthesis may be inhibited at 24 h *K*~F~ exposure. In addition, the MexGHI-OpmD efflux pump system has been implicated in the efflux of xenobiotics, including the antibiotic norfloxacin and the heterocyclic dye acriflavine \[[@B37]\], and the transport of phenazine molecules \[[@B38]\]. Interestingly, the downregulation of the MexGHI-OpmD system observed in the RNA-seq data was coupled with a reduction in the phenazine biosynthesis process *K*~F~ at 24 h of *P. aeruginosa* treated with *K*~F~ ([Table 5](#tab5){ref-type="table"}). The opportunistic pathogen *P. aeruginosa* is well known for its production of bright blue phenazine pyocyanin, which contributes to the colouration of sputum and pus associated with infections and interferes with multiple host cellular functions \[[@B39]\]. In response to *K*~F~ treatment, *P. aeruginosa* repressed the expression of the secretory machinery (Sec system), responsible for the secretion of virulence factors, extracellular degradative enzymes, and other toxins, enabling adaptation to a wide range of ecological niches \[[@B40]\]. Therefore, taken together, these data reveal the marked remodelling of gene transcription characterized by an early and late reduction in the expression of several genes associated with virulence factors of *P. aeruginosa* in response to *K*~F~ treatment.

Bacteria can form biofilms on living or nonliving surfaces and can be prevalent in natural, industrial, and hospital settings. Bacterial motility and adhesion are critical for biofilm development \[[@B41]\]. The type IV pili in *P. aeruginosa* play an important role in the adherence to epithelial cells and microbial intra and interspecies competition, while flagella filament-mediated motility enables bacteria to reach a surface and then divide and spread along the surface \[[@B42]\]. In response to *K*~F~ treatment at 24 h, the downregulation of type IV and flagellin type B (*fliC*) genes observed in RNA-seq ([Table 5](#tab5){ref-type="table"}) was paralleled by the decreased expression of genes involved in biofilm formation in *P. aeruginosa* ([Table 6](#tab6){ref-type="table"}). These findings may indicate that *K*~F~ treatment affects genes involved in biofilm formation and motility. As a consequence of these combined factors, we thus hypothesise that the swimming and biofilm formation ability of *P. aeruginosa* would be inhibited under *K*~F~ treatment conditions.

The treatment of *P. aeruginosa* with *K*~F~ for 24 h led to the decreased expression of genes encoding the aminoacyl-tRNA synthetases glutamine, glycine, leucine, lysine, proline, valine, and aspartate. Furthermore, genes associated with the biosynthesis of several amino acids, including histidine, arginine, cysteine, and tryptophan, were also expressed at reduced levels in *K*~F~-treated samples at 24 h ([Table 5](#tab5){ref-type="table"}). RNA-seq data showed that the downregulation of the expression of genes *hslVU*, *htpG*, and *grpE* involved in the degradation of unfolded or misfolded proteins that accumulate in the periplasm \[[@B43]\], following heat shock or other stress conditions was coupled with the decreased expression of the *clpB* gene encoding an ATP-dependent protease, which functions as part of the chaperone network essential for the recovery of stress-induced protein aggregates \[[@B44]\] ([Table 6](#tab6){ref-type="table"}). The altered expression of these genes at two *K*~F~ exposure time points may be indicative of their essential function in cellular responses to environmental stress. As a consequence of these combined factors, we thus assume that protein synthesis in *P. aeruginosa* might be affected by *K*~F~ treatment.

5. Conclusion {#sec5}
=============

The crisis of the antibiotic resistance demands to be met with concerted efforts across many disciplines and areas of expertise. Natural products are mainstays of drugs and still play an essential role in providing chemical diversity, despite a reduced interest shown by pharmaceutical companies. Herein, we could prove efficacy of *K*~F~ against one of the most notorious pathogen *P. aeruginosa*. The *K*~F~ compound is more likely to have multitargets inside the test *P. aeruginosa*. To the best of our knowledge, the current study is the first report describing the antibacterial effect of *K*~F~ on *P. aeruginosa* at the gene expression level through transcriptomic analysis, revealing the regulation of various genes involved in cellular processes that lead to the destabilization of this bacterium. The transcriptomic analysis showed that *K*~F~ increases the expression of genes involved in the electron transport chain (NADH-I), resulting in the induction of ATP synthesis. *K*~F~ also increased the expression of genes associated with ATP-binding cassette transporters, flagella, type III secretion system proteins, and DNA replication and repair, which may further affect nutrient uptake, motility, and growth. The major mechanisms through which *K*~F~ seems to exert its antibacterial effect on *P. aeruginosa* are by the repression of a broad range of virulence factors associated with LPS biosynthesis, iron homeostasis, cytotoxic pigment pyocyanin production, and motility and adhesion that are representative of an acute *P. aeruginosa* infection profile. Taken together, the present study is a good demonstration of the therapeutic usefulness of the natural product from plant in validating the traditional medicine, i.e., *M. malabathricum*, very common in Malaysia. Specifically, attenuations of bacterial virulence factors are likely to be effective solutions in this therapeutic area. Although the current study offers a possible regulatory network of *P. aeruginosa* induced by *K*~F~ treatment, further studies will focus on the protein level expression of the target genes. In general, this study has generated scientific evidence that natural product research is perfectly positioned to address and solve the present bacterial resistance crisis and the closely linked antibiotic discovery gap.

AP:

:   Adaptation, protection

SFs:

:   Secreted factors (toxins, enzymes, and alginate)

AABM:

:   Amino acid biosynthesis and metabolism

T-RNA-PD:

:   Transcription, RNA processing, and degradation

BCPGCs:

:   Biosynthesis of cofactors, prosthetic groups, and carriers

TRs:

:   Transcriptional regulators

CWLC:

:   Cell wall/LPS/capsule

TPTMD:

:   Translation, post-translational modification, degradation

CHSPs:

:   Chaperones and heat shock proteins

TSMs:

:   Transport of small molecules

CT:

:   Chemotaxis

TCRSs:

:   Two-component regulatory systems

DNA-RRMR:

:   DNA replication, recombination, modification, and repair

HUU:

:   Hypothetical, unclassified, and unknown

EM:

:   Energy metabolism

PSEA:

:   Protein secretion/export apparatus

FAPM:

:   Fatty acid and phospholipid metabolism

PEs:

:   Putative enzymes

MA:

:   Motility and attachment

MPs:

:   Membrane proteins.
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![Histograms representing the number of genes based on their functional classes for *P. aeruginosa* and for the upregulated expression (blue bars) and downregulated expression (red bars) genes among the 1031 significantly expressed genes at both 6 h and 24 h exposure to *K*~F~ (0.5 mg/mL). The numbers in parentheses indicate the total number of genes for each functional class in both groups.](IJMICRO2020-6915483.001){#fig1}

![Venn diagram showing the overlap of significantly upregulated expression of genes at 6 h and 24 h exposure to *K*~F~ (0.5 mg/mL). (a) Venn diagram for early time point (6 h). (b) Venn diagram for late time point (24 h).](IJMICRO2020-6915483.002){#fig2}

![Classification of differentially upregulated and downregulated (total of 228) genes into six groups based on their functional classes at 6 h and 24 h exposure to *K*~F~ (0.5 mg/mL). Group I consisted of genes with upregulated expression at 6 h and 24 h. Group II consisted of genes with upregulated expression at 6 h without significant changes at 24 h. Group III consisted of genes with downregulated expression at 6 h without significant changes at 24 h. Group IV consisted of genes with upregulated expression at 24 h without significant changes at 6 h. Group V consisted of genes with downregulated expression at 24 h without significant changes at 6 h. Group VI consisted of genes with downregulated expression at 6 h and 24 h.](IJMICRO2020-6915483.003){#fig3}

###### 

List of the group I genes with upregulated expression at 6 h and 24 h.

  Genes    6 h fold change   *p* value      24 h fold change   *p* value      Description                                                                 Functional class
  -------- ----------------- -------------- ------------------ -------------- --------------------------------------------------------------------------- ------------------
  *agtA*   20.45             0              9.21               0              ABC-type spermidine/putrescine transport systems, ATPase components         TSMs
  *agtB*   32.34             0              8.09               0              ABC-spermidine/putrescine-binding periplasmic protein                       TSMs
  *agtC*   25.25             0              4.57               0              ABC-type spermidine/putrescine transport system, permease component I       TSMs; MPs
  *agtD*   15.20             1.68*E* − 03   3.00               2.68*E* − 07   ABC-type spermidine/putrescine transport system, permease component II      TSMs; MPs
  PA4500   8.02              0              3.11               0              ABC-type dipeptide transport system, periplasmic component                  TSMs
  PA3190   7.60              2.64*E* − 04   2.09               0              ABC-type sugar transport system, periplasmic component                      TSMs
  PA3514   6.95              6.67*E* − 04   5.08               0              ABC-type nitrate/sulfonate/bicarbonate transport system, ATPase component   TSMs
  *spcS*   35.38             0              3.94               0              Specific *Pseudomonas* chaperone for ExoS, SpcS                             SFs; PSEA
  *pcrV*   14.54             0              5.89               0              Type III protein secretion system complex                                   PSEA
  *pcrH*   7.52              0              4.94               0              Regulatory protein PcrH                                                     SFs; PSEA
  *popB*   11.31             0              4.79               0              Translocator protein PopB                                                   PSEA
  *popD*   9.67              0              3.48               0              Translocator outer membrane protein PopD precursor                          PSEA
  *exsC*   10.98             0              4.09               0              ExsC, exoenzyme S synthesis protein C precursor                             PSEA
  *exsE*   8.61              2.32*E* − 06   4.62               0              ExsE                                                                        PSEA
  *exsD*   11.895            0              4.572              0              ExsD                                                                        PSEA
  *pscG*   7.60              4.15*E* − 03   2.31               6.10*E* − 03   Type III export protein PscG                                                PSEA; CHSPs
  *exoS*   13.43             0              6.71               0              Exoenzyme S                                                                 SFs
  *exoT*   9.36              0              4.50               0              Exoenzyme T                                                                 SFs
  *exoY*   31.08             0              5.82               0              Adenylate cyclase ExoY                                                      SFs

###### 

List of the group II genes with upregulated expression at 6 h.

  Genes     6 h (fold change)   *p* value      Description                                          Functional class
  --------- ------------------- -------------- ---------------------------------------------------- ------------------
  *hisC1*   4.814               0.013          Histidinol-phosphate aminotransferase                AABM
  *HisE*    3.111               4.06*E* − 08   Phosphoribosyl-ATP pyrophosphohydrolase              AABM
  *ArgF*    2.723               2.16*E* − 03   Ornithine carbamoyltransferase, anabolic             AABM
  *ArgJ*    2.601               9.75*E* − 03   Glutamate N-acetyltransferase                        AABM
  *ilvA1*   2.117               0.021          Threonine dehydratase, biosynthetic                  AABM
  *LeuA*    5.244               0              2-Isopropylmalate synthase                           AABM
  *LeuC*    2.387               7.87*E* − 12   3-Isopropylmalate dehydratase large subunit          AABM
  *PheA*    2.1                 0.018          Chorismate mutase                                    AABM
  *RpsL*    2.56                0              30S ribosomal protein S12                            TPTMD
  *RplA*    3.679               0              50S ribosomal protein L1                             TPTMD
  *TrpS*    3.501               1.62*E* − 05   Tryptophanyl-tRNA synthetase                         TPTMD; AABM
  *TyrZ*    3.239               0              Tyrosyl-tRNA synthetase 2                            TPTMD; AABM
  *GlyQ*    2.431               0              Glycyl-tRNA synthetase alpha chain                   TPTMD; AABM
  *GlnE*    2.912               3.52*E* − 07   Glutamine synthetase adenylyltransferase             TPTMD
  *ValS*    2.356               3.57*E* − 10   Valyl-tRNA synthetase                                TPTMD; AABM
  *ProS*    2.274               2.36*E* − 09   Prolyl-tRNA synthetase                               TPTMD; AABM
  *CysS*    2.152               2.30*E* − 05   Cysteinyl-tRNA synthetase                            TPTMD; AABM
  *IleS*    2.02                1.72*E* − 08   Isoleucyl-tRNA synthetase                            TPTMD; AABM
  *InfC*    7.182               0              Translation initiation factor IF-3                   TPTMD
  *fusA2*   2.313               5.73*E* − 07   Elongation factor G                                  TPTMD
  *PrfC*    3.564               0.013          Peptide chain release factor 3                       TPTMD
  PA5195    3.589               0.028          Probable heat shock protein                          CHSPs
  *HscB*    3.187               2.35*E* − 05   Heat shock protein HscB                              CHSPs
  *AccB*    6.303               0              Biotin carboxyl carrier protein (BCCP)               FAPM
  *AccD*    3.579               6.23*E* − 12   Acetyl-CoA carboxylase beta subunit                  FAPM
  *FabA*    2.258               2.67*E* − 06   Beta-hydroxydecanoyl-ACP dehydrase                   FAPM
  *FabB*    2.96                0              Beta-ketoacyl-ACP synthase I                         FAPM
  *NorB*    8.614               1.58*E* − 03   Nitric oxide reductase subunit B                     EM
  *Anr*     3.84                0              Transcriptional regulator Anr                        EM
  *NuoB*    4.162               0              NADH dehydrogenase I chain B                         EM
  *NuoD*    2.982               0              NADH dehydrogenase I chain C,D                       EM
  *NuoF*    2.657               5.14*E* − 09   NADH dehydrogenase I chain F                         EM
  *NuoG*    2.761               0              NADH dehydrogenase I chain G                         EM
  *NuoH*    3.026               9.62*E* − 06   NADH dehydrogenase I chain H                         EM
  *NuoI*    7.185               3.21*E* − 14   NADH dehydrogenase I chain I                         EM
  *NuoJ*    4.172               3.27*E* − 03   NADH dehydrogenase I chain J                         EM
  *NuoL*    3.459               0              NADH dehydrogenase I chain L                         EM
  *NuoM*    2.884               5.40*E* − 04   NADH dehydrogenase I chain M                         EM
  *NuoN*    5.008               2.12*E* − 07   NADH dehydrogenase I chain N                         EM
  *FlgB*    5.197               0              Flagellar basal body rod protein FlgB                CWLC; MA
  *FlgC*    2.907               8.96*E* − 10   Flagellar basal body rod protein FlgC                CWLC; MA
  *FlgD*    4.125               4.38*E* − 14   Flagellar basal body rod modification protein FlgD   CWLC; MA
  *FlgE*    4.984               0              Flagellar hook protein FlgE                          CWLC; MA
  *FlgF*    4.623               2.03*E* − 14   Flagellar basal body rod protein FlgF                CWLC; MA
  *FlgG*    3.297               0              Flagellar basal body rod protein FlgG                CWLC; MA
  *FlgI*    2.4                 0.01           Flagellar P-ring protein precursor FlgI              CWLC; MA
  *FlgJ*    4.057               3.23*E* − 13   Flagellar protein FlgJ                               CWLC; MA
  *FlgK*    3.85                2.24*E* − 10   Flagellar hook-associated protein 1 FlgK             CWLC; MA
  *FliE*    4.534               1.18*E* − 11   Flagellar hook-basal body complex protein FliE       CWLC; MA
  *FliF*    3.433               0              Flagella M-ring outer membrane protein precursor     CWLC; MA
  *FliG*    2.635               6.34*E* − 10   Flagellar motor switch protein FliG                  CWLC; MA

###### 

List of the group III genes with downregulated expression at 6 h.

  Genes    6 h (fold change)   24 h (fold change)   Description                                                             Functional class
  -------- ------------------- -------------------- ----------------------------------------------------------------------- ------------------
  *Pys2*   −4.084              0                    Pyocin S2                                                               AP; SFs
  *imm2*   −2.56               0                    Pyocin S2 immunity protein                                              AP
  *cobO*   −2.684              8.27*E* − 04         Cob (I) alamin adenosyltransferase                                      BCPGCs
  *cobD*   −4.229              0.012                Cobalamin biosynthetic protein CobD                                     BCPGCs
  *cobU*   −4.306              7.36*E* − 04         Nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase   BCPGCs
  *cobJ*   −4.9                0                    Precorrin-3 methylase CobJ                                              BCPGCs

###### 

List of the group IV genes with upregulated expression at 24 h.

  Genes    24 h (fold change)   *p* value      Description   Functional class
  -------- -------------------- -------------- ------------- ------------------
  *dctP*   2.879                0              DctP          MPs; TSMs
  *dctQ*   2.419                1.04*E* − 06   DctQ          MPs; TSMs
  *dctM*   2.206                4.35E − 05     DctM          MPs; TSMs

###### 

List of the group V genes with downregulated expression at 24 h.

  Genes     24 h (fold change)   *p* value      Description                                                                                   Functional class
  --------- -------------------- -------------- --------------------------------------------------------------------------------------------- ---------------------
  *pchR*    −3.116               2.23*E* − 15   Transcriptional regulator PchR                                                                TRs
  PA0471    −2.863               1.61*E* − 05   Fe^2+^-dicitrate sensor, membrane component                                                   TCRSs; MPs; TRs
  *fiuI*    −2.171               1.62*E* − 03   Fe^2+^-dicitrate sensor, membrane component                                                   TRs
  PA1300    −2.201               5.72*E* − 09   Sigma-70 factor, ECF subfamily                                                                TRs
  PA1301    2.386                0.014          Probable transmembrane sensor                                                                 MPs; TRs
  PA3899    −3.481               0              Probable sigma-70 factor, ECF subfamily                                                       TRs
  PA3900    −2.505               0.019          Fe^2+^-dicitrate sensor, membrane component                                                   MPs; TRs
  PA4895    −5.965               1.26*E* − 09   Fe^2+^-dicitrate sensor, membrane component                                                   MPs; TRs
  PA4896    −3.644               8.33*E* − 11   Sigma-70 factor, ECF subfamily                                                                TRs
  PA0149    −3.859               1.15*E* − 08   Probable sigma-70 factor, ECF subfamily                                                       TRs
  *femI*    −3.628               0              ECF sigma factor, FemI                                                                        TRs
  PA2896    −2.495               0              Probable sigma-70 factor, ECF subfamily                                                       TRs
  *tonB1*   −2.067               0              Periplasmic protein TonB, links inner and outer membranes                                     TSMs
  PA4156    −11.36               0              Probable TonB-dependent receptor                                                              TSMs
  *fumC1*   −4.599               0              Fumarate hydratase                                                                            EM
  *sodM*    −3.955               0              Superoxide dismutase                                                                          AP
  *hemO*    −3.581               0              Heme oxygenase                                                                                BCPGCs
  PA0853    −3.242               2.66*E* − 13   Oxidoreductase                                                                                PEs
  PA3768    −2.622               0              Probable metallo-oxidoreductase                                                               PEs
  *phzA1*   −4.295               1.53*E* − 07   Probable phenazine biosynthesis protein                                                       SFs
  *phzB1*   −4.708               −4.708         Probable phenazine biosynthesis protein                                                       SFs
  *phzC1*   −2.577               −2.577         Phenazine biosynthesis protein PhzC                                                           SFs
  *phzA2*   −2.625               −2.625         Probable phenazine biosynthesis protein                                                       SFs
  *phzB2*   −3.848               −3.848         Probable phenazine biosynthesis protein                                                       SFs
  *phzM*    −2.125               1.14*E* − 10   Probable phenazine-specific methyltransferase                                                 PEs
  *phzS*    −2.241               0              Flavin-containing monooxygenase                                                               PEs
  *secA*    −2.166               0              Secretion protein SecA                                                                        PSEA
  *secB*    −2.579               0              Secretion protein SecB                                                                        PSEA
  *secD*    −3.234               0              Secretion protein SecD                                                                        PSEA; MPs
  *mexG*    −2.119               7.29*E* − 03   Membrane protein                                                                              MPs
  *mexH*    −9.088               0              Probable resistance-nodulation-cell division (RND) efflux membrane fusion protein precursor   TSMs
  *mexI*    −5.758               0              Probable resistance-nodulation-cell division (RND) efflux transporter                         TSMs; MPs
  *opmD*    −3.241               0              Outer membrane protein precursor                                                              TSMs; MPs
  *lpxB*    −2.148               7.24*E* − 03   Lipid A-disaccharide synthase                                                                 CWLC
  *lpxA*    −2.274               0              UDP-N-acetylglucosamine acyltransferase                                                       CWLC
  *waaP*    −3.174               2.75*E* − 14   Lipopolysaccharide kinase WaaP                                                                CWLC
  *waaG*    −2.437               0              UDP-glucose:(heptosyl) LPS alpha 1,3-glucosyltransferase WaaG                                 CWLC
  *waaF*    −2.283               1.48*E* − 08   Heptosyltransferase II                                                                        CWLC
  PA4998    −2.482               6.80*E* − 12   Aminoglycoside 3′-phosphotransferase (APH) and choline kinase family                          CWLC
  PA5007    −3.124               4.80*E* − 08   Mn^2+−^dependent serine/threonine protein kinase                                              PEs
  PA5008    −3.187               7.22*E* − 15   RIO-like serine/threonine protein kinase fused to N-terminal HTH domain                       PEs
  *rmlA*    −2.554               0              Glucose-1-phosphate thymidylyltransferase                                                     CWLC
  *pilD*    −2.377               0              Type 4 prepilin peptidase PilD                                                                SFs; PSEA; MA
  *pilF*    −2.053               0              Type 4 fimbrial biogenesis protein PilF                                                       PSEA; MA
  *pilM*    −3.074               0              Type 4 fimbrial biogenesis protein PilM                                                       MA
  *pilN*    −3.871               0              Type 4 fimbrial biogenesis protein PilN                                                       MA
  *pilO*    −4.476               0              Type 4 fimbrial biogenesis protein PilO                                                       MA
  *pilP*    −3.956               0              Type 4 fimbrial biogenesis protein PilP                                                       MA
  *pilQ*    −3.219               0              Type 4 fimbrial biogenesis outer membrane protein PilQ precursor                              MA
  *pilU*    −2.226               0              Twitching motility protein PilU                                                               MA
  *pilV*    −2.382               0              Type 4 fimbrial biogenesis protein PilV                                                       MA
  *pilW*    −2.516               0              Type 4 fimbrial biogenesis protein PilW                                                       MA
  *pilX*    −2.366               0              Type 4 fimbrial biogenesis protein PilX                                                       MA
  *pilY1*   −2.025               0              Type 4 fimbrial biogenesis protein PilY1                                                      MA
  *pilG*    −2.713               0              Twitching motility protein PilG                                                               TCRSs; MA; CT
  *pilH*    −3.112               0              Twitching motility protein PilH                                                               TCRSs; MA; CT
  *pilI*    −2.731               2.20*E* − 09   Twitching motility protein PilI                                                               MA; CT
  *pilJ*    −5.282               0              Twitching motility protein PilJ                                                               MA; CT
  *Vfr*     −2.047               0              Transcriptional regulator vfr                                                                 TRs
  *chpA*    −2.124               0              Component of chemotactic signal transduction system                                           TCRSs; MA; CT
  *chpB*    −2.315               1.15*E* − 05   Probable methylesterase                                                                       CT
  *fliC*    −2.145               0              Flagellin type B                                                                              MA
  *rpsK*    −2.592               0              30S ribosomal protein S11                                                                     TPTMD
  *rplA*    −2.375               0              50S ribosomal protein L1                                                                      TPTMD
  *glnS*    −2.102               0              Glutaminyl-tRNA synthetase                                                                    TPTMD; AABM
  *glyS*    −2.162               2.11*E* − 13   Glycyl-tRNA synthetase beta chain                                                             TPTMD; AABM
  *leuS*    −2.131               0              Leucyl-tRNA synthetase                                                                        TPTMD; AABM
  *lysS*    −2.38                0              Lysyl-tRNA synthetase                                                                         TPTMD; AABM
  *proS*    −2.764               0              Prolyl-tRNA synthetase                                                                        TPTMD; AABM
  *valS*    −2.13                0              Valyl-tRNA synthetase                                                                         TPTMD; AABM
  *aspS*    −2.129               0              Aspartyl-tRNA synthetase                                                                      T-RNA-PD; TPTMD
  *hisF1*   −3.599               1.02*E* − 11   Imidazole glycerol-phosphate synthase, cyclase subunit                                        AABM
  *hisG*    −2.863               2.04*E* − 10   ATP-phosphoribosyltransferase                                                                 AABM
  *argB*    −2.436               0              Acetylglutamate kinase                                                                        AABM
  *argG*    −2.428               0              Argininosuccinate synthase                                                                    AABM
  *argH*    −2.127               0              Argininosuccinate lyase                                                                       AABM
  *cysM*    −3.436               0              Cysteine synthase B                                                                           AABM
  *trpA*    −4.405               0              Tryptophan synthase alpha chain                                                               AABM
  *trpB*    −6.527               0              Tryptophan synthase beta chain                                                                AABM
  *hslU*    −4.255               0              Heat shock protein HslU                                                                       CHSPs
  *hslV*    −3.742               0              Heat shock protein HslV                                                                       CHSPs
  *htpG*    −2.835               0              Heat shock protein HtpG                                                                       CHSPs
  *htpX*    −2.557               0              Heat shock protein HtpX                                                                       AP
  *dnaA*    −2.631               0              Chromosomal replication initiation protein                                                    DNA-RRMR
  *dnaJ*    −2.528               0              DnaJ protein                                                                                  DNA-RRMR; CHSPs; AP
  *dnaK*    −3.087               0              DnaK protein                                                                                  DNA-RRMR; CHSPs; AP
  *holC*    −2.701               5.25*E* − 09   DNA polymerase III, chi subunit                                                               DNA-RRMR
  *mutL*    −2.563               0              DNA mismatch repair protein MutL                                                              DNA-RRMR
  *Phr*     −3.012               2.14*E* − 12   Deoxyribodipyrimidine photolyase                                                              DNA-RRMR
  *sbcD*    −2.056               2.40*E* − 13   Exonuclease SbcD                                                                              DNA-RRMR
  *recG*    −2.105               7.52*E* − 16   ATP-dependent DNA helicase RecG                                                               DNA-RRMR; TRs
  *uvrC*    −2.622               0              Excinuclease ABC subunit C                                                                    DNA-RRMR
  *uvrD*    −3.412               0              DNA helicase II                                                                               DNA-RRMR
  *ccmE*    −2.297               7.41*E* − 10   Cytochrome C-type biogenesis protein CcmE                                                     EM
  *ccmG*    −2.001               3.24*E* − 06   Cytochrome C biogenesis protein CcmG                                                          TPTMD; CHSPs; EM
  PA1600    −2.819               2.31*E* − 06   Probable cytochrome c                                                                         EM
  PA4571    −2.708               0              Probable cytochrome c                                                                         EM
  PA4133    −5.344               0              Cytochrome c oxidase subunit (cbb3-type)                                                      EM
  *ccoO1*   −2.475               0              Cytochrome c oxidase, cbb3-type, CcoO subunit                                                 EM
  *ccoQ1*   −2.235               1.16*E* − 04   Cytochrome c oxidase, cbb3-type, CcoQ subunit                                                 EM
  *nuoD*    −2.216               0              NADH dehydrogenase I chain C,D                                                                EM
  *nuoE*    −2.162               9.15*E* − 13   NADH dehydrogenase I chain E                                                                  EM
  *narK1*   −2.541               2.23*E* − 15   Nitrite extrusion protein 1                                                                   MPs; TSMs
  *narK2*   −5.637               0              Nitrite extrusion protein 2                                                                   MPs; TSMs
  *narG*    −4.157               0              Respiratory nitrate reductase alpha chain                                                     EM
  *narJ*    −2.386               0.014          Respiratory nitrate reductase delta chain                                                     EM
  *narL*    −2.09                0              Two-component response regulator NarL                                                         EM; TCRSs
  *Dnr*     −2.065               8.03*E* − 14   Transcriptional regulator Dnr                                                                 TRs

###### 

List of the group VI genes with downregulated expression at 6 h and 24 h.

  Genes    6 h (fold change)   *p* value       24 h (fold change)   *p* value   Description                                                                         Functional class
  -------- ------------------- --------------- -------------------- ----------- ----------------------------------------------------------------------------------- ------------------
  *htpG*   −  4.483            0               − 2.835              0           Heat shock protein HtpG                                                             CHSPs
  *HslV*   − 5.567             0               − 3.742              0           Heat shock protein HslV                                                             CHSPs
  *HslU*   − 3.379             0               − 4.255              0           Heat shock protein HslU                                                             CHSPs
  *grpE*   − 2.265             0               − 3.718              0           Heat shock protein GrpE                                                             DNA-RRMR; CHSPs
  *ClpB*   − 5.018             0               − 2.312              0           ATP-binding subunits of clp protease and DnaK/DnaJ chaperones                       TPTMD
  *BfiR*   − 2.707             0.033           − 2.584              0           Response regulator                                                                  TRs; TCRSs
  *BfiS*   − 4.934             6.31*E* −  15   − 2.714              0           Signal transduction histidine kinase regulating C4-dicarboxylate transport system   TCRSs

###### 

Transcript level comparison of *P. aeruginosa* genes between qRT-PCR and NGS. qRT-PCR is the mean of two biological replicates with three technical replicates for each gene. Reference gene (*nadB*): L-aspartate oxidase, *uvrD*, and *sodM* were downregulated at 24 h with no change at 6 h; *fumC1* was upregulated at 6 h and downregulated at 24 h; *rpsL* was upregulated at 6 h with NC at 24 h exposure.

  Genes ID      Gene symbol   NGS         qRT-PCR          Primers       Length (bp)    Description                   
  ------------- ------------- ----------- ---------------- ------------- -------------- ------------------------ ---- ---------------------------
  PA5443        *uvrD*        NC          −3.412 ± 0       NC            −2.54 ± 0.01   GTGCGCCTGTCCAATAC        17   DNA helicase II
                                                                                        GCCTTCGAAGTTGAGGATAG     20    
  PA4468        *sodM*        NC          −3.955 ± 0       NC            −2.44 ± 0.01   GAGCAGCCGGTGGAAAGTCT     20   Superoxide dismutase
                                                                                        GCGACATCACGGTCCAGAAC     20    
  PA4470        *fumC1*       3.618 ± 0   −4.599 ± 0       3.48 ± 0.69   −5.39 ± 0      TCGGGCAACTTCGAACTGAA     20   Fumarate hydratase
                                                                                        GAGCTTGCCCTGGTTGACCT     20    
  PA4268        *rpsL*        2.56 ± 0    NC               3.53 ± 0.53   NC             CGGCACTGCGTAAGGTATGC     20   30S ribosomal protein S12
                                                                                        CCCGGAAGGTCCTTTACACG     20    
  PA0761^*∗*^   *nadB*                    Reference gene                                CTACCTTTATACCAGCAATCCC   22   L-aspartate oxidase
                                                                                        CGGTGATGAGGAAACTCTTG     20    

[^1]: Academic Editor: Todd R. Callaway
